Reinhart Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,415,537
Closed -$77.3M – 73
2026
Q2
$77.3M Sell
7,415,537
-2,666,446
-26% -$29.8M 1.76% 31
2026
Q1
$120M Buy
10,081,983
+1,981,198
+24% +$20.3M 3.45% 8
2025
Q4
$80.7M Buy
8,100,785
+773,727
+11% +$7.39M 2.42% 22
2025
Q3
$65.6M Buy
7,327,058
+14,432
+0.2% +$134K 2.13% 22
2025
Q2
$69M Buy
7,312,626
+76,364
+1% +$674K 2.36% 17
2025
Q1
$78.4M Buy
7,236,262
+969,408
+15% +$9.75M 2.86% 12
2024
Q4
$59.7M Buy
6,266,854
+68,212
+1% +$690K 2.3% 19
2024
Q3
$69.6M Buy
6,198,642
+1,929,339
+45% +$20.5M 2.64% 13
2024
Q2
$42.7M Buy
4,269,303
+59,092
+1% +$600K 1.77% 23
2024
Q1
$48.5M Buy
4,210,211
+144,516
+4% +$1.23M 1.97% 20
2023
Q4
$29.6M Buy
4,065,695
+443,518
+12% +$3.5M 1.3% 33
2023
Q3
$33M Buy
3,622,177
+570,497
+19% +$6.84M 1.71% 22
2023
Q2
$37.1M Buy
3,051,680
+2,135,721
+233% +$23.8M 1.88% 18
2023
Q1
$11.4M Buy
915,959
+419,281
+84% +$7.71M 0.62% 67
2022
Q4
$9.55M Sell
496,678
-3,922
-0.8% -$82.9K 0.52% 73
2022
Q3
$9.4M Sell
500,600
-770,791
-61% -$15.8M 0.58% 71
2022
Q2
$22.9M Buy
+1,271,391
New +$20.6M 1.26% 30

Other funds holding AHCO

Reinhart Partners's AHCO Position: Q3 2026 in Review

Reinhart Partners sold out of AdaptHealth (AHCO) in Q3 2026, closing a stake of 7,415,537 shares — an estimated $77.3M sold.

Reinhart Partners first reported a position in AHCO in Q2 2022 and held it in 17 quarters. The position peaked at $120M in Q1 2026. 14 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Reinhart Partners reported no remaining AdaptHealth position as of Q3 2026 after selling out during the quarter.
  • Reinhart Partners sold 7,415,537 AdaptHealth shares in Q3 2026, an estimated $77.3M.
  • Reinhart Partners first reported a position in AdaptHealth in Q2 2022 and held it in 17 quarters.
  • Reinhart Partners's AdaptHealth position peaked at $120M in Q1 2026.
  • 14 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Reinhart Partners's 13F filing for Q3 2026, filed 9 Oct 2026.